Source file signed link, expires in 15 minutes
Extracted text 2
Page 1
PT TAISHO PHARMACEUTICAL INDONESIA, Tbk
Laporan Posisi Keuangan
31 Desember 2024 dan 2023
(Dinyatakan dalam ribuan Rupiah, kecuali dinyatakan lain)
31 Desember 31 Desember Kenaikan(penurunan)
2024 2023 Rp %
ASET
ASET LANCAR
Kas dan setara kas 690,838,846 488,900,346 201,938,500 41.30%
Piutang usaha
Pihak berelasi 76,358,364 31,087,723 45,270,641 145.62%
Pihak ketiga 113,650,103 113,358,495 291,608 0.26%
Piutang lain-lain
Pihak berelasi - -
Pihak ketiga 4,236,633 9,303,293 (5,066,660) -54.46%
Persediaan - bersih 94,203,631 123,412,687 (29,209,056) -23.67%
Biaya dibayar di muka dan
uang muka 7,307,649 17,242,180 (9,934,531) -57.62%
Pajak dibayar di muka 7,753,291 19,173,808 (11,420,517) -59.56%
Jumlah Aset Lancar 994,348,517 802,478,532 191,869,985 23.91%
ASET TIDAK LANCAR
Aset pajak tangguhan 16,522,715 19,655,705 (3,132,990) -15.94%
Taksiran tagihan pajak 61,175,709 61,175,709 - 0.00%
Aset tetap, bersih 179,875,386 153,313,448 26,561,938 17.33%
Aset lain-lain 1,100,361 1,100,361 - 0.00%
Jumlah Aset Tidak Lancar 258,674,171 235,245,223 23,428,948 9.96%
JUMLAH ASET 1,253,022,688 1,037,723,755 215,298,933 20.75%
Page 2
PT TAISHO PHARMACEUTICAL INDONESIA, Tbk
Laporan Posisi Keuangan
31 Desember 2024 dan 2023
(Dinyatakan dalam ribuan Rupiah, kecuali dinyatakan lain)
31 Desember 31 Desember Kenaikan(penurunan)
2024 2023 Rp %
LIABILITAS
Liabilitas jangka pendek
Utang usaha
Pihak ketiga 51,596,048 27,953,895 23,642,153 84.58%
Sub-total 51,596,048 27,953,895 23,642,153 84.58%
Utang lain-lain
Pihak berelasi 13,185,410 7,410,351 5,775,059 77.93%
Pihak ketiga 18,369,874 19,878,149 (1,508,275) -7.59%
Sub-total 31,555,284 27,288,500 4,266,784 15.64%
Liabilitas imbalan kerja
jangka pendek 4,454,944 3,359,184 1,095,760 32.62%
Utang Pajak
Pajak penghasilan badan 22,252,545 5,466,577 16,785,968 307.07%
Pajak lain-lain 2,439,307 1,248,280 1,191,027 95.41%
Akrual 47,183,700 58,278,488 (11,094,788) -19.04%
Liabilitas sewa 2,271,406 2,271,406 - 0.00%
Jumlah liabilitas jangka pendek 161,753,234 125,866,330 35,886,904 28.51%
Liabilitas jangka panjang
Kewajiban imbalan kerja 14,543,164 13,630,003 913,161 6.70%
Liabilitas sewa 1,867,259 3,024,855 (1,157,596) -38.27%
Jumlah Liabilitas 178,163,657 142,521,188 35,642,469 25.01%
Ekuitas
Modal saham
Saham preferen
modal dasar, ditempatkan
dan disetor penuh
972.000 saham, dengan
nilai nominal Rp 1.000
(Rupiah penuh) per saham 972,000 972,000 - 0.00%
Saham biasa, modal dasar
11.988.000 saham,
ditempatkan dan disetor penuh
9.268.000 saham dengan nilai nominal
Rp.1.000 (Rupiah penuh) per saham 9,268,000 9,268,000 - 0.00%
Tambahan modal disetor 59,484,195 59,484,195 - 0.00%
Saham treasuri - - - 0.00%
Saldo laba
Dicadangkan 8,228,052 8,178,052 50,000 0.61%
Belum dicadangkan 996,906,784 817,300,320 179,606,464 21.98%
Jumlah Ekuitas 1,074,859,031 895,202,567 179,656,464 20.07%
JUMLAH LIABILITAS
DAN EKUITAS 1,253,022,688 1,037,723,755 215,298,933 20.75%
- -
Kenaikan di Aset melebih 20% karena kenaikan di Kas dan Setara Kas. Kenaikan di Ekuitas melebihi 20% karena Laba tahun berjalan.
Names mentioned 1 people and organisations named in the text · linked when the evidence is strong
unresolved
org
PT TAISHO PHARMACEUTICAL INDONESIA
p.1 ×2
Extraction attempts how the parser did, and what it refused
Nothing structured was extracted from this document — the attempts below say why.
No extraction attempted yet.
Other files in this announcement 6
FS 30.06.2024.pdf
done
instance.zip
done
FinancialStatement-2024-II-SQBB.xlsx
done
inlineXBRL.zip
done